1-4 of 4
Annie-Claude Benichou, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Subcutaneous Omacetaxine in Chronic or Accelerated Chronic Myeloid Leukemia Resistant to Two or More Tyrosine-Kinase Inhibitors Including Imatinib,

Jorge E. Cortes, Franck E. Nicolini, MD, PhD, Meir Wetzler, MD, Jeffrey H. Lipton, MD, PhD, Luke P. Akard, MD, Adam Craig, MD, PhD, Nisha Nanda, PhD, Carrie Dial, BS, Annie-Claude Benichou, MD, Katie Cairati, MS, Michele Baccarani, MD, Gerard T. Kennealey, MD, Hagop M. Kantarjian
Journal: Blood
Blood (2011) 118 (21): 3761.
https://doi.org/10.1182/blood.V118.21.3761.3761
Published: 2011
Journal Articles

Subcutaneous Omacetaxine (OM) Treatment of Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Patients Following Multiple Tyrosine Kinase Inhibitor (TKI) Failure

Jorge E. Cortes, MD, Meir Wetzler, MD, Jeff Lipton, MD, FRCPC, Franck E Nicolini, MD, PhD, Michele Baccarani, MD, Maria R Baer, M.D., H. Jean Khoury, David Cram, PharmD, Eric D. Humphriss, BA, Annie-Claude Benichou, MD, Adam Craig, MD, PhD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2010) 116 (21): 2290.
https://doi.org/10.1182/blood.V116.21.2290.2290
Published: 2010
Journal Articles

Safety and Efficacy of Subcutaneous (SC) Omacetaxine Mepesuccinate in Imatinib(IM)-Resistant Chronic Myeloid Leukemia (CML) Patients (pts) with the T315I Mutation – Results of An Ongoing Multicenter Phase II Study.

Jorge Cortes, MD, H. Jean Khoury, MD, Sélim Corm, MD, Franck E Nicolini, MD, PhD, Jeffrey H. Lipton, MD, PhD, Dan Jones, MD, PhD, Andreas Hochhaus, MD, Adam R Craig, MD, PhD, Annie-Claude Benichou, MD, Eric Humphriss, Hagop Kantarjian
Journal: Blood
Blood (2008) 112 (11): 3239.
https://doi.org/10.1182/blood.V112.11.3239.3239
Published: 2008
Journal Articles

Safety and Efficacy Study of Subcutaneous Homoharringtonine (SC HHT) in Imatinib (IM)-Resistant Chronic Myeloid Leukemia (CML) with the T315I Mutation - Initial Report of a Phase II Trial.

H. Jean Khoury, MD, Mauricette Michallet, MD, Selim Corm, MD, Lydia Roy, MD, Dan Jones, MD, PhD, Andreas Hochhaus, MD, Hagop Kantarjian, MD, Annie-Claude Benichou, MD, Richard Schwartz, MD, Jorge Cortes, MD
Journal: Blood
Blood (2007) 110 (11): 1050.
https://doi.org/10.1182/blood.V110.11.1050.1050
Published: 2007